Tumour necrosis factor‐α antagonists as therapies for vitiligo

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2133|7-0963|3|635-635

ISSN： 0007-0963

Source： BRITISH JOURNAL OF DERMATOLOGY, Vol.7-0963, Iss.3, 2015-09, pp. : 635-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tumour necrosis factor‐α antagonists as therapies for vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 635-635

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 173, Iss. 3, 2015-09 ,pp. : 641-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Tumour necrosis factor‐α inhibition can stabilize disease in progressive vitiligo

By  

BRITISH JOURNAL OF DERMATOLOGY, Vol. 7-0963, Iss. 3, 2015-09 ,pp. : 641-650

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acne conglobata and adalimumab: use of tumour necrosis factor‐α antagonists in treatment‐resistant acne conglobata, and review of the literature

By  

CLINICAL & EXPERIMENTAL DERMATOLOGY, Vol. 40, Iss. 4, 2015-06 ,pp. : 383-386

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting tumour necrosis factor-α in hypoxia and synaptic signalling

By O'Connor J.  

Irish Journal of Medical Science, Vol. 182, Iss. 2, 2013-06 ,pp. : 157-162

Springer Publishing Company

Access to resources Recommend Favorite